Betamethasone 1 MG/ML Topical Cream — RxCUI 197407
RxNorm drug concept · Semantic clinical drug
RxCUI 197407
Semantic clinical drug · SCD
● Current RxNorm concept 15 FDA products
22 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI197407
Official nameBetamethasone 1 MG/ML Topical Cream
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asbetamethasone 0.1 % Topical Cream; betamethasone 1 MG/ML (as betamethasone valerate 1.2 MG/ML) Topical Cream
FDA products mapped15
Package NDCs mapped22
Reported Medicaid activity (SDUD)149,806 prescriptions · 48 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Betamethasone Topical: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It calms inflammation and itching in skin conditions that respond to steroids. The ointment is for people 13 and older. Sernivo spray is used for plaque psoriasis.
- Use it only on your skin, as directed. With the lotion, a few drops once or twice daily is rubbed in gently. Wash your hands afterward and keep it out of your eyes.
- Stop once your skin is under control. The strong lotion is limited to 2 weeks. If you see no improvement in 2 weeks, check back with your doctor.
- Burning, stinging, itching or pain where you apply it are the most common. Skin thinning can also happen. Call your doctor about vision changes or skin that gets worse.
🕸️ Concept Web — How Betamethasone 1 MG/ML Topical Cream Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Betamethasone 1 MG/ML Topical Cream
RxCUI 197407 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Betamethasone
1514IN
-
Betamethasone
-
Dose forms 4
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Betamethasone Topical Cream
377613SCDF -
Betamethasone Topical Product
1153804SCDG -
Topical Cream
316982DF -
Topical Product
1151122DFG
-
Betamethasone Topical Cream
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Betamethasone 1 MG/ML
340091SCDC
-
Betamethasone 1 MG/ML
Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Betamethasone 1 MG/ML
SCDC · 340091 -
Betamethasone Topical Cream
SCDF · 377613 -
Betamethasone Topical Product
SCDG · 1153804
📦 FDA Products & Package NDCs
15 products · 22 package NDCs
22 package NDCs map to RxCUI 197407 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00168-0033-15 | 15 g in 1 TUBE (0168-0033-15) | Betamethasone Valerate | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | 1983-08-31 |
| 00168-0033-46 | 45 g in 1 TUBE (0168-0033-46) | Betamethasone Valerate | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | 1983-08-31 |
| 00168-0040-15 | 15 g in 1 TUBE (0168-0040-15) | Betamethasone Valerate | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | 1983-08-31 |
| 00168-0040-46 | 45 g in 1 TUBE (0168-0040-46) | Betamethasone Valerate | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | 1983-08-31 |
| 00168-0041-60 | 60 mL in 1 BOTTLE (0168-0041-60) | Betamethasone Valerate | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | 1983-08-31 |
| 00713-0326-15 | 1 TUBE in 1 CARTON (0713-0326-15) / 15 g in 1 TUBE | Betamethasone Valerate | Cosette Pharmaceuticals, Inc. | 2015-08-27 |
| 00713-0326-37 | 1 TUBE in 1 CARTON (0713-0326-37) / 45 g in 1 TUBE | Betamethasone Valerate | Cosette Pharmaceuticals, Inc. | 2015-08-27 |
| 00713-0327-15 | 1 TUBE in 1 CARTON (0713-0327-15) / 15 g in 1 TUBE | Betamethasone Valerate | Cosette Pharmaceuticals, Inc. | 2015-08-27 |
| 00713-0327-37 | 1 TUBE in 1 CARTON (0713-0327-37) / 45 g in 1 TUBE | Betamethasone Valerate | Cosette Pharmaceuticals, Inc. | 2015-08-27 |
| 50090-1647-00 | 1 TUBE in 1 CARTON (50090-1647-0) / 15 g in 1 TUBE | BETAMETHASONE VALERATE | A-S Medication Solutions | 2015-01-19 |
| 50090-3134-01 | 1 TUBE in 1 CARTON (50090-3134-1) / 45 g in 1 TUBE | BETAMETHASONE VALERATE | A-S Medication Solutions | 2017-09-08 |
| 50090-3794-01 | 1 TUBE in 1 CARTON (50090-3794-1) / 45 g in 1 TUBE | Betamethasone Valerate | A-S Medication Solutions | 2018-11-08 |
| 50090-4696-00 | 1 TUBE in 1 CARTON (50090-4696-0) / 15 g in 1 TUBE | Betamethasone Valerate | A-S Medication Solutions | 2019-11-07 |
| 51672-1269-01 | 1 TUBE in 1 CARTON (51672-1269-1) / 15 g in 1 TUBE | BETAMETHASONE VALERATE | Sun Pharmaceutical Industries, Inc. | 1988-01-06 |
| 51672-1269-06 | 1 TUBE in 1 CARTON (51672-1269-6) / 45 g in 1 TUBE | BETAMETHASONE VALERATE | Sun Pharmaceutical Industries, Inc. | 1988-01-06 |
| 68071-4278-05 | 15 g in 1 BOX (68071-4278-5) | BETAMETHASONE VALERATE | NuCare Pharmaceuticals,Inc. | 2018-02-08 |
| 68071-5224-05 | 15 g in 1 BOX (68071-5224-5) | Betamethasone Valerate | NuCare Pharmaceuticals,Inc. | 2020-03-30 |
| 68788-7451-01 | 1 TUBE in 1 CARTON (68788-7451-1) / 15 g in 1 TUBE | BETAMETHASONE VALERATE | Preferred Pharmaceuticals, Inc. | 2019-01-31 |
| 68788-7451-04 | 1 TUBE in 1 CARTON (68788-7451-4) / 45 g in 1 TUBE | BETAMETHASONE VALERATE | Preferred Pharmaceuticals, Inc. | 2019-01-31 |
| 68788-8450-01 | 15 g in 1 TUBE (68788-8450-1) | Betamethasone Valerate | Preferred Pharmaceuticals Inc. | 2023-05-26 |
| 68788-8450-04 | 45 g in 1 TUBE (68788-8450-4) | Betamethasone Valerate | Preferred Pharmaceuticals Inc. | 2023-05-26 |
| 71205-0040-15 | 15 g in 1 TUBE (71205-040-15) | Betamethasone Valerate | Proficient Rx LP | 2018-05-01 |
Observed labelers:
E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC (5) ·
A-S Medication Solutions (4) ·
Cosette Pharmaceuticals, Inc. (4) ·
NuCare Pharmaceuticals,Inc. (2) ·
Preferred Pharmaceuticals Inc. (2) ·
Preferred Pharmaceuticals, Inc. (2)
· +2 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.